Her2 low breast carcinoma Clinical Trials
Conditions / Her2 low breast carcinoma
Delta Trials tracks 6 clinical trials for Her2 low breast carcinoma in its publicly accessible dataset. Among the listed trials, 3 open for participant enrollment and 0 trials have reached completion. This research is carried out at 12 clinical sites around the world. An additional 3 trials have active registrations outside the recruiting and completed categories. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the research landscape.
Trial Status
6
Total Trials
3
Recruiting
0
Completed
3
Other Active
0
Terminated since 2020
12
Study Locations
Browse by location (12 total)
- Chicago, United States 1 trialAll trials in Chicago, United States
- New Lenox, United States 1 trialAll trials in New Lenox, United States
- Tampa, United States 1 trialAll trials in Tampa, United States
- Houston, United States 1 trialAll trials in Houston, United States
- Minneapolis, United States 1 trialAll trials in Minneapolis, United States
- Boston, United States 1 trialAll trials in Boston, United States
- Orland Park, United States 1 trialAll trials in Orland Park, United States
- Villejuif, France 1 trialAll trials in Villejuif, France
- Birmingham, United States 1 trialAll trials in Birmingham, United States
- San Francisco, United States 1 trialAll trials in San Francisco, United States
- Guangzhou, China 1 trialAll trials in Guangzhou, China
- Zhengzhou, China 1 trialAll trials in Zhengzhou, China